logo-loader
ASX:ACW OTC:ATGGF

Actinogen Medical Ltd

Receive alerts
Market:
ASX
Price
0.0080 AUD
Day Change
-82.22%
Market Cap:
$30.96 m
52 weeks high
0.07
52 weeks low
0.0050

In brief

Actinogen Medical is a biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. 

The company is currently developing its lead compound, Xanamem®, as a revolutionary new therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact.

Snapshot

  • Actinogen Medical identifies 30% slowing of Alzheimer's progression in older patients
  • Actinogen Medical targets Alzheimer’s treatment gap in projected $20BN market
  • Actinogen Medical with Proactive at ASX Small and Mid Cap Conference

Insight Widest with the analysis, Proactive gives perspectives that others don't.